39th International Conference on Antiviral Research (ICAR 2026)

The 39th International Conference on Antiviral Research (ICAR 2026) is dedicated to the latest advancements and breakthroughs in antiviral research.

Topics

• Broad Spectrum Antiviral Drugs, Non-respiratory Biothreat Viruses, and Pandemic Preparedness
• Arboviruses
• Coronaviruses, Influenza, RSV, and Other Respiratory Viruses
• Chronic, Latent, and Persistent Viruses - Retroviruses and Herpesviruses
• Hepatotropic and GI Viruses

Who should Attend

Scientists, researchers, and industry professionals from:

• Startups
• Academia
• Industry
• Small, medium and large pharmaceutical companies
• Governmental and nongovernmental organizations
• Areas of critical importance for immediate or future antiviral development